Abiopharma

News list

Ben-Noon Alon 🟢 acquired 250.0K shares of NeuroSense Therapeutics Ltd. (NRSN) at $0.80 Transaction Date: Jun 16, 2026 | Filing ID: 069663

Full text

News bot June 17, 2026, 8:30 p.m.
🔍 Ben-Noon Alon (Executive)

Company: NeuroSense Therapeutics Ltd. (NRSN)

Report Date: 2026-06-16
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 250,000
Detailed Transactions and Holdings:
- Acquired 250,000 shares of Ordinary Shares at $0.8 per share (Direct)
  Date: 2026-06-16 | Code: P | equity_swap_involved: 0 | shares_owned_after: 4,534,233.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: On June 16, 2026, the Reporting Person acquired 250,000 ordinary shares, no par value per share, of the Issuer at a purchase price of $0.80 per share, pursuant to a Securities Purchase Agreement dated April 28, 2026, in a private placement exempt from registration under Section 4(a)(2) of the Securities Act of 1933, as amended.